Bioorganic and Medicinal Chemistry (ISSN 1464-3391, 0968-0896) is a journal published by Elsevier in the United Kingdom. It covers Biochemistry, Genetics and Molecular Biology, Chemistry and Pharmacology. It is indexed in Scopus, Web of Science, MEDLINE, PubMed and HEC. Recorded metrics: impact factor 3.5, Scopus Q2, Web of Science Q2, CiteScore 5.6 and HEC W-Category. Article processing charge: USD 3,940. This profile brings together the journal's ISSN, publisher, country, subject area, HEC category, Scopus data, SJR and SCImago rank, Web of Science data, impact factor, indexing, open access status, APC, aims and scope, about the journal, author instructions, journal website and registration details from the most reputable indexes, in one place.
Journal title
Bioorganic and Medicinal Chemistry
ISSN
1464-3391, 0968-0896
Subject area
BiochemistryGenetics and Molecular BiologyChemistryPharmacologyToxicology and PharmaceuticsDrug DiscoveryOrganic ChemistryPharmaceutical ScienceClinical BiochemistryMolecular BiologyMolecular Medicine
Indexed
ScopusWeb of ScienceMEDLINEPubMedHEC
Scopus Quartile
Q2
WoS Quartile
Q2
Impact Factor
3.5
Country
United Kingdom
Publisher
Elsevier
SJR
0.582
Open access
No
APC (USD)
3940
About the journal
The Tetrahedron Journal for Research at the Interface of Chemistry and Biology Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The Journal welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets the reporting of the discovery, design or optimization of potent new compounds or biological agents the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data the reporting of "first-in-class" new therapeutic compounds the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism methodological advances that are chemistry-based and which significantly impact on medicine or biology the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states the development of materials for specific therapeutic targeting All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
Aims and Scope
The Tetrahedron Journal for Research at the Interface of Chemistry and Biology Bioorganic & Medicinal Chemistry publishes complete accounts of research of outstanding significance and timeliness on all aspects of molecular interactions at the interface of chemistry and biology, together with critical review articles. The journal publishes reports of experimental results in medicinal chemistry, chemical biology and drug discovery and design, emphasizing new and emerging advances and concepts in these fields. The aim of the journal is to promote a better understanding at the molecular level of life processes, and living organisms, as well as the interaction of these with chemical agents. The Journal welcomes papers on: the medicinal chemistry and associated biology (including target identification and validation) of established or new disease targets the reporting of the discovery, design or optimization of potent new compounds or biological agents the analysis and discussion of structure-activity relationships and pharmacological issues relevant to drug design and action using in vitro and in vivo models, including the use of computational techniques when closely linked to experimental data the reporting of "first-in-class" new therapeutic compounds the chemical biology or bioorganic/bioinorganic chemistry that significantly advances knowledge of a biological mechanism methodological advances that are chemistry-based and which significantly impact on medicine or biology the preparation and examination of biotherapeutics for the treatment of pathophysiological disease states the development of materials for specific therapeutic targeting All manuscripts will be rigorously peer-reviewed by independent experts following an initial assessment by the Editors. Please note that BMC is not suitable for straightforward reports of incremental advances. Above all the presentation of a rational basis and a sound underlying hypothesis for the work is of particular importance, whatever its exact field.
Quick answers about Bioorganic and Medicinal Chemistry
Is Bioorganic and Medicinal Chemistry HEC recognised?
Yes. The catalogue records Bioorganic and Medicinal Chemistry in HEC category W of the HEC Journal Recognition System, where W is the highest and Y the lowest category. Confirm the current category on HEC's HJRS website before you submit.
Is Bioorganic and Medicinal Chemistry indexed in Scopus?
Yes. Bioorganic and Medicinal Chemistry is listed as Scopus-indexed, in quartile Q2, with a CiteScore of 5.6. Check its current status on the Scopus Sources page.
Is Bioorganic and Medicinal Chemistry in Web of Science?
Yes. Bioorganic and Medicinal Chemistry is listed as a Web of Science journal in the Science Citation Index Expanded (SCIE), with Web of Science quartile Q2. Confirm on Clarivate's Master Journal List.
What is the impact factor of Bioorganic and Medicinal Chemistry?
The recorded journal impact factor of Bioorganic and Medicinal Chemistry is 3.5. Clarivate updates impact factors every year in Journal Citation Reports.
Is Bioorganic and Medicinal Chemistry open access, and what does it charge?
Bioorganic and Medicinal Chemistry is not recorded as fully open access and its APC is USD 3,940. Fees change, so check the journal's website before you submit.
Who publishes Bioorganic and Medicinal Chemistry?
Bioorganic and Medicinal Chemistry is published by Elsevier in United Kingdom, under ISSN 1464-3391 and 0968-0896.
Research profile
19,278articles indexed
651,718citations
215h-index
3.162-year mean citedness
1858first year indexed
Main research topics: Heterocyclic Compound Synthesis and Bioactivity, Synthesis and Characterization of Heterocyclic Compounds, Computational Drug Discovery Methods, Chemical Synthesis and Analysis, DNA and Nucleic Acid Chemistry, Carbohydrate Chemistry and Synthesis.
Source: OpenAlex (CC0), retrieved 21 November 2026. Counts cover works OpenAlex has indexed and differ from Scopus and Web of Science.